On Friday, Aptevo Therapeutics Inc (NASDAQ: APVO) was -12.45% drop from the session before settling in for the closing price of $0.24. A 52-week range for APVO has been $0.14 – $10.80.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -17.88% over the past five years. When this article was written, the company’s average yearly earnings per share was at -81.72%. With a float of $18.50 million, this company’s outstanding shares have now reached $18.51 million.
Let’s look at the performance matrix of the company that is accounted for 40 employees. In terms of profitability, gross margin is 65.3%, operating margin of -2727.72%, and the pretax margin is -2662.31%.
Aptevo Therapeutics Inc (APVO) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Aptevo Therapeutics Inc stocks. The insider ownership of Aptevo Therapeutics Inc is 0.06%, while institutional ownership is 6.80%.
Aptevo Therapeutics Inc (APVO) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -6.46 earnings per share (EPS) during the time that was better than consensus figure (set at -18.04) by 11.58. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.28 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -81.72% per share during the next fiscal year.
Aptevo Therapeutics Inc (NASDAQ: APVO) Trading Performance Indicators
You can see what Aptevo Therapeutics Inc (APVO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.70.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -25.45, a number that is poised to hit -0.28 in the next quarter and is forecasted to reach -1.03 in one year’s time.
Technical Analysis of Aptevo Therapeutics Inc (APVO)
Aptevo Therapeutics Inc (NASDAQ: APVO) saw its 5-day average volume 1.56 million, a negative change from its year-to-date volume of 3.79 million. As of the previous 9 days, the stock’s Stochastic %D was 3.02%. Additionally, its Average True Range was 0.05.
During the past 100 days, Aptevo Therapeutics Inc’s (APVO) raw stochastic average was set at 14.10%, which indicates a significant increase from 0.70% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 178.59% in the past 14 days, which was lower than the 198.25% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2295, while its 200-day Moving Average is $1.6441. Nevertheless, the first resistance level for the watch stands at $0.2305 in the near term. At $0.2501, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.2603. If the price goes on to break the first support level at $0.2007, it is likely to go to the next support level at $0.1905. The third support level lies at $0.1709 if the price breaches the second support level.
Aptevo Therapeutics Inc (NASDAQ: APVO) Key Stats
There are 18,512K outstanding shares of the company, which has a market capitalization of 3.42 million. As of now, sales total 0 K while income totals -17,410 K. Its latest quarter income was 0 K while its last quarter net income were -5,100 K.
